Skip to main content
IRS-authorized e-file provider · not the IRS

Nonprofit · EIN 52-2184099

DIABETES NATIONAL INSTITUTE INC

Tax-exempt · CHEVY CHASE, MD 20815

Financials

$21K$66K2023$23K$41K2024
Revenue Expenses · by fiscal year end
Financials of DIABETES NATIONAL INSTITUTE INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$23,249$41,008-$17,759$120,560$750$119,810
December 31, 2023990$20,981$65,879-$44,898$138,318$750$137,568
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$23,213
Program service revenue
$0
Investment income
$36
Other revenue
$0

Expenses

Grants and similar amounts paid
$35,000
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Accounting fees
$750
Program services (functional)
$38,404
Management and general (functional)
$2,604

Balance sheet and other

Total assets, start of year
$138,318
Total assets, end of year
$120,560
Total liabilities, end of year
$750
Net assets, end of year
$119,810
Land, buildings and equipment
$107
Net assets without donor restrictions
$119,810
Gross receipts
$23,249
Employees
0
Volunteers
10
Year formed
1999
State of legal domicile
MD

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
MARIE HELLINGERSECRETARY & DIR
Trustee or director, Officer
2$0
DOUGLAS SOBELEX. DIR.
Key employee
2$0
SUSAN HOECHSETTERPRES.DIRECTOR
Trustee or director, Officer
5$0
JOSEPH HELLINGERDIRECTOR
Trustee or director
2$0
SHIRLEY WOODSVICE PRES.& DIRECTOR
Trustee or director, Officer
2$0
JOHN BOWMANTREASURER & DIRECTOR
Trustee or director, Officer
2$0
990 for the year ended December 31, 2023: 6 people
NameTitleHours / weekCompensation
MARIE HELLINGERSECRETARY & DIR
Trustee or director, Officer
2$0
DOUGLAS SOBELEX. DIR.
Key employee
2$0
SUSAN HOECHSETTERPRES.DIRECTOR
Trustee or director, Officer
5$0
JOSEPH HELLINGERTREASURER & DIRECTOR
Trustee or director, Officer
2$0
SHIRLEY WOODSVICE PRES.& DIRECTOR
Trustee or director, Officer
2$0
GENE WILLHOFTDIRECTOR
Trustee or director
2$0

Address and contacts

Address (IRS master file)
9109 LEVELLE DR, CHEVY CHASE, MD 20815-5605
Principal officer (990 for 2024)
Douglas Sobel, 9109 Levelle Dr, Chevy Chase, MD 20815
Signed the 990
SUSAN HOECHSETTER, PRESIDENT
Phone
(301) 906-7283
Return prepared by
James R Turner & Company PC

Mission

SUPPORT AND CONDUCT DIABETES RESEARCH AND EDUCATIONAL PROGRAMS

990 for the year ended December 31, 2024

Program accomplishments

  • DIABETES RESEARCH
    Expenses $35,000
  • EDUCATIONAL PROGRAMS AND OTHER ACTIVITIES FOR CHILDREN AND OTHER INTERESTED INDIVIDUALS
    Expenses $3,404

What it must file and when

IRS records say it files Form 990-N (e-Postcard). Gross receipts normally $50,000 or less. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

File the 2025 990-N for DIABETES NATIONAL INSTITUTE INC

Due May 15, 2026 · e-filed with the IRS by 990.tax, an IRS-authorized e-file provider

IRS record

EIN
52-2184099
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1999
Accounting year ends
December
Files
Form 990-N (e-Postcard)
Category (NTEE)
Medical research (H80)
Assets (IRS master file)
$120,560
Income (IRS master file)
$23,249

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$23,249$41,008$120,560XML
990December 2023$20,981$65,879$138,318XML
990December 2022$18,207$49,721$182,466IRS
990December 2021–––IRS
990December 2020–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 52-2184099).

Questions about DIABETES NATIONAL INSTITUTE INC

What is the EIN of DIABETES NATIONAL INSTITUTE INC?
The employer identification number (EIN) of DIABETES NATIONAL INSTITUTE INC is 52-2184099.
Is DIABETES NATIONAL INSTITUTE INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1999.
Are donations to DIABETES NATIONAL INSTITUTE INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does DIABETES NATIONAL INSTITUTE INC file?
Form 990-N (e-Postcard). Gross receipts normally $50,000 or less.
When is the next return of DIABETES NATIONAL INSTITUTE INC due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did DIABETES NATIONAL INSTITUTE INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of DIABETES NATIONAL INSTITUTE INC?
The 990 for the year ended December 31, 2024 names Douglas Sobel.
Who are the officers and directors of DIABETES NATIONAL INSTITUTE INC?
The 990 for the year ended December 31, 2024 lists 6 people; 0 received compensation from the organization.
How much revenue does DIABETES NATIONAL INSTITUTE INC have?
On its 990 for the year ended December 31, 2024 it reported revenue of $23,249, expenses of $41,008 and total assets of $120,560 at year end.

Other nonprofits in CHEVY CHASE

All nonprofits in CHEVY CHASE · Maryland · Medical research